Fundraising Fox
Find your path to Brad
Sign up to see every warm intro you have to Brad
- Paths you didn't know you had: your email and LinkedIn already hold routes to Brad. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Brad Morie oversees the licensing of RCT's biotechnology programs, including Pichia Classic, Pichia GlycoSwitch, ClearColi and other protein expression platforms. He previously held business development and licensing roles at Ajinomoto Bio-Pharma Services, Catalent, Lonza, BIOCRATES and Los Alamos National Laboratory.
Contact· self-published, not guessed
Invests in
Biotech
Colleagues at Research Corporation Technologies
Frequently asked questions
- Who is Brad Morie?
- Brad Morie oversees the licensing of RCT's biotechnology programs, including Pichia Classic, Pichia GlycoSwitch, ClearColi and other protein expression platforms. He previously held business development and licensing roles at Ajinomoto Bio-Pharma Services, Catalent, Lonza, BIOCRATES and Los Alamos National Laboratory.
- Where does Brad Morie work?
- Brad Morie is Senior Director, Biotechnologies at Research Corporation Technologies.
- What does Brad Morie invest in?
- Brad Morie invests in Biotech.
About this profile. Compiled from public sources — Research Corporation Technologies's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights